We are live on ! Find out more
GH

Geisinger Health Portfolio holdings

AUM $344M
1-Year Est. Return 4.22%
This Fund
S&P 500
This Quarter Est. Return
-3.15%
1 Year Est. Return
+4.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$295M
AUM Growth
-$17.3M
Cap. Flow
-$7.68M
Cap. Flow %
-2.6%
Top 10 Hldgs %
100%
Holding
5
New
Increased
3
Reduced
1
Closed
1

Top Sells

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$7.34M
2
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$3.05M

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
1
iShares Core US Aggregate Bond ETF
AGG
$138B
$164M 55.42%
1,739,557
+14,006
+0.8% +$1.35M
HYG icon
2
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$80.9M 27.41%
1,097,542
+17,999
+2% +$1.34M
IWB icon
3
iShares Russell 1000 ETF
IWB
$47.1B
$36.3M 12.31%
154,732
+67
+0% +$16.4K
EFV icon
4
iShares MSCI EAFE Value ETF
EFV
$28.3B
$14.3M 4.85%
292,815
-61,521
-17% -$3.05M
IEFA icon
5
iShares Core MSCI EAFE ETF
IEFA
$186B
-108,797
Closed -$7.34M

Similar funds

Geisinger Health's Q3 2023 Portfolio in Review

As of Q3 2023, Geisinger Health held 5 positions worth $295M, down 5.5% from $312M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Geisinger Health's Q3 2023 filing shows 3 increased, 1 reduced and 1 closed positions. The largest sale was iShares Core MSCI EAFE ETF, an estimated $7.34M.

  • Geisinger Health added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $1.35M increase.
  • Geisinger Health's biggest Q3 2023 reduction was iShares MSCI EAFE Value ETF, cutting an estimated $3.05M.
  • Geisinger Health fully exited iShares Core MSCI EAFE ETF in Q3 2023, selling an estimated $7.34M.
  • Geisinger Health's ten largest holdings make up 100% of its $295M portfolio in Q3 2023.
  • Geisinger Health opened 0 new positions and closed 1 in Q3 2023.
  • Geisinger Health's portfolio value fell 5.5% quarter-over-quarter to $295M.

Based on Geisinger Health's 13F filing for Q3 2023, filed 9 Nov 2023.